Novel role of Stat1 in the development of docetaxel resistance in prostate tumor cells (Q40284731)

19 September 2017

Novel role of Stat1 in the development of docetaxel resistance in prostate tumor cells (English)

1 reference

19 September 2017

1 reference

1 reference

S G Patterson

1

1 reference

19 September 2017

S Wei

2

1 reference

19 September 2017

X Chen

3

1 reference

19 September 2017

D A Sallman

4

1 reference

19 September 2017

D L Gilvary

5

1 reference

19 September 2017

B Zhong

6

1 reference

19 September 2017

J Pow-Sang

7

1 reference

19 September 2017

T Yeatman

8

1 reference

19 September 2017

J Y Djeu

9

1 reference

19 September 2017

language of work or name

English

0 references

publication date

1 May 2006

1 reference

19 September 2017

1 reference

19 September 2017

25

1 reference

19 September 2017

45

1 reference

19 September 2017

6113-6122

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.onc.1209632

19 September 2017

0 references

cites work

Constitutive activation of STAT proteins in the HDLM-2 and L540 Hodgkin lymphoma-derived cell lines supports cell survival.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209632

Chemotherapy in advanced androgen-independent prostate cancer 1990-1999: a decade of progress?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209632

STATs and gene regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209632

Chemotherapy: targeting the mitochondrial cell death pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209632

Pathological and molecular mechanisms of prostate carcinogenesis: implications for diagnosis, detection, prevention, and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209632

Stat3 activation in prostatic carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209632

Perturbed IFN-gamma-Jak-signal transducers and activators of transcription signaling in tuberous sclerosis mouse models: synergistic effects of rapamycin-IFN-gamma treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209632

Overcoming multidrug resistance in taxane chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209632

The biochemistry of apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209632

Cellular stress response and apoptosis in cancer therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209632

Lack of association between enhanced TRPM-2/clusterin expression and increased apoptotic activity in sex-hormone-induced prostatic dysplasia of the Noble rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209632

STAT proteins and transcriptional responses to extracellular signals

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209632

Apoptosis: a link between cancer genetics and chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209632

Docetaxel (Taxotere) - an update.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209632

Interleukin-6 protects LNCaP cells from apoptosis induced by androgen deprivation through the Stat3 pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209632

Study of the effects of interferon a on several human hepatoma cell lines: analysis of the signalling pathway of the cytokine and of its effects on apoptosis and cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209632

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209632

Survival of docetaxel-resistant prostate cancer cells in vitro depends on phenotype alterations and continuity of drug exposure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209632

Chemistry and chemical biology of taxane anticancer agents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209632

Alterations in the post-translational modification and intracellular trafficking of clusterin in MCF-7 cells during apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209632

Up-regulation of TRPM-2, MMP-7 and ID-1 during sex hormone-induced prostate carcinogenesis in the Noble rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209632

Cancer epidemiology in the last century and the next decade

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209632

The current role of chemotherapy in metastatic hormone-refractory prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209632

Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209632

Modulation of different clusterin isoforms in human colon tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209632

STAT-1: a novel regulator of apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209632

Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209632

STAT1: a modulator of chemotherapy-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209632

Clusterin/apolipoprotein J in human aging and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209632

Silencing expression of the clusterin/apolipoprotein j gene in human cancer cells using small interfering RNA induces spontaneous apoptosis, reduced growth ability, and cell sensitization to genotoxic and oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209632

Regulation of the innate and adaptive immune responses by Stat-3 signaling in tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209632

Overexpression of the cytoprotective protein clusterin decreases radiosensitivity in the human LNCaP prostate tumour model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209632

Clusterin Has Chaperone-like Activity Similar to That of Small Heat Shock Proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209632

Clinical and biomarker correlates of androgen-independent, locally aggressive prostate cancer with limited metastatic potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209632

7 January 2021

Stat3 enhances the growth of LNCaP human prostate cancer cells in intact and castrated male nude mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209632

7 January 2021

Immune selection and emergence of aggressive tumor variants as negative consequences of Fas-mediated cytotoxicity and altered IFN-gamma-regulated gene expression.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209632

7 January 2021

Hormonal therapy for prostate cancer: primum non nocere

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209632

7 January 2021

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209632

1 reference

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1209632

1 reference

Dimensions Publication ID

19 September 2017

0 references

1 reference